Carrier Global vs Eaton
CARR and ETN side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CARR and ETN compare
Eaton is the larger company, worth 3.1 times as much as Carrier Global ($137B against $44.3B).
Eaton grew revenue faster over the last twelve months (15.5% versus 3.3% for Carrier Global).
Eaton keeps more of each dollar of sales as profit, with a net margin of 12.8% compared with −7.9% at Carrier Global.
Both pay dividends: Carrier Global yields 1.3% and Eaton 0.93%.
Eaton scores higher on the StockData Score (14 against 5 for Carrier Global), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CARR | ETN |
|---|---|---|
| Size and price | ||
| Market cap | $44.3B | $137B |
| Share price | $54.20 | $352.97 |
| Change, 1 year | −3.2% | −4.4% |
| Change, 5 years | −5.2% | 105% |
| Beta (5Y) | 1.24 | 1.09 |
| Employees | 47K | 97K |
| StockData Score | ||
| Total score | 5 | 14 (better) |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 0 | 4 (better) |
| Health score | 1 | 3 (better) |
| Dividend score | 2 | 4 (better) |
| Valuation | ||
| P/E | – | 35.9× |
| P/S | 1.9× (better) | 4.6× |
| P/B | – | 6.8× |
| EV/EBITDA | 283× | 24.4× (better) |
| P/FCF | 18.6× (better) | 34.8× |
| PEG | – | 1.85 |
| FCF yield | 5.4% (better) | 2.9% |
| Fair value | $36.45 | $229.23 |
| Margin of safety | −48.7% (better) | −54.0% |
| Growth | ||
| Revenue growth (TTM) | 3.3% | 15.5% (better) |
| Revenue growth, 5Y average | 4.5% | 9.0% (better) |
| Net income growth (TTM) | −145% | −2.5% (better) |
| EPS growth (TTM) | −150% | −1.2% (better) |
| EPS growth, 5Y average | −5.2% | 24.5% (better) |
| Profitability | ||
| Gross margin | – | 35.9% |
| Operating margin | −4.8% | – |
| Net margin | −7.9% | 12.8% (better) |
| FCF margin | 10.4% | 13.1% (better) |
| Return on equity | – | 19.7% |
| Financial health | ||
| Debt / equity | – | 1.02 |
| Net debt / EBITDA | 52.16 | 3.09 (better) |
| Current ratio | 1.00 | 1.24 (better) |
| Altman Z-score | 2.13 | 3.18 (better) |
| Piotroski F-score | 4 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 1.3% (better) | 0.93% |
| Payout ratio | – | 43.5% |
| Years of dividend growth | 0 | 15 (better) |
| Dividend growth, 5Y average | 19.2% (better) | 7.3% |
| Buyback yield | 3.7% (better) | 0.40% |
| Shareholder yield | 5.0% (better) | 1.3% |
| Ownership | ||
| Held by institutions | 88.7% | 85.3% |
| Held by insiders | 4.8% | 0.19% |
| Insider net buying, 12 months | −$750M | −$22.1M (better) |
| Superinvestors holding | 1 | 1 |
| Short interest, % of float | 2.4% | 1.8% |
Go deeper
- CARR stock overview
- CARR income statement
- CARR valuation and score
- ETN stock overview
- ETN income statement
- ETN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.